Analysis of the correlation of these neuropathological markers of CNS prions disease (AIF1 + microglia; CD44+ and GFAP+ astrocytes; PrPd) showed the variance across all the prion agent strain/recipient mouse combinations studied (Supplementary Table 5). This evidence concerns the gene AIF1 and prion disease.